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Summary
Pseudoachondroplasia (PSACH) and multiple epiphys-
eal dysplasia (MED) are autosomal dominant osteo-
chondrodysplasias that result in mild to severe short-
limb dwarfism and early-onset osteoarthrosis. PSACH
and some forms of MED result from mutations in the
gene for cartilage oligomeric matrix protein (COMP;
OMIM 600310 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?600310]). We report the
identification of COMP mutations in an additional 14
families with PSACH or MED phenotypes. Mutations
predicted to result in single–amino acid deletions or sub-
stitutions, all in the region of the COMP gene encoding
the calmodulin-like repeat elements, were identified in
patients with moderate to severe PSACH. We also iden-
tified within this domain a missense mutation that pro-
duced MED Fairbank. In two families, one with mild
PSACH and the second with a form of MED, we iden-
tified different substitutions for a residue in the carboxyl-
terminal globular region of COMP. Both the clinical
presentations of these two families and the identification
of COMP-gene mutations provide evidence of pheno-
typic overlap between PSACH and MED. These data
also reveal a role for the carboxyl-terminal domain in
the structure and/or function of COMP.
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Introduction
Pseudoachondroplasia (PSACH; OMIM 177170 [http:/
/www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim
?177170]) and multiple epiphyseal dysplasia (MED;
OMIM 132400 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim/dispmim?132400]) are autosomal
dominant osteochondrodysplasias that result in mild to
severe short-limb dwarfism and early-onset osteoar-
throsis (International Working Group on Constitutional
Diseases of Bone 1992). PSACH is the clinically more
severe phenotype, characterized bymarked short stature,
short fingers, loose joints with ligamentous laxity, de-
formity of the legs, and scoliosis. Radiographic features
include small irregular epiphyses with delayed ossifica-
tion, irregular metaphyses, and delayed ossification of
the annular epiphyses of the vertebrae, resulting in a
characteristic anterior beaking of the vertebral bodies
that is apparent on lateral projection. Milder cases of
PSACH exhibit similar radiographic features, but short
stature is less pronounced and there is less deformity
than in more severe cases (Maroteaux et al. 1980; Ri-
moin et al. 1994). MED, which is divided into the more
severe Fairbank type (Fairbank 1947) and the milder
Ribbing type (Ribbing 1937), is less severe than PSACH.
Patients with MED exhibit normal stature, or mild short
stature, and early-onset osteoarthrosis that becomes ap-
parent in mid- to late childhood. Radiographically, the
epiphyses are irregular and show poor ossification, but
metaphyseal abnormalities are mild or absent. The spine
is typically radiographically normal. Morphological
studies of cartilage from PSACH and MED patients
show accumulation of material in the rough endoplasmic
reticulum (RER) of chondrocytes (Maynard et al. 1972;
Stanescu et al. 1977, 1982, 1993; Rimoin et al. 1994).
In most PSACH and in some MED cases, the accumu-
lated material forms a unique lamellar structure (May-
nard et al. 1972; Stanescu et al. 1977, 1982, 1993).
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Initially, the mild and severe PSACH phenotypes were
linked to markers in the pericentromeric region of chro-
mosome 19 (Briggs et al. 1993; Hecht et al. 1993), and
they were subsequently found to result from mutations
in the gene for cartilage oligomeric matrix protein
(COMP) (Briggs et al. 1995a; Hecht et al. 1995). Some
forms ofMEDwere also linked to this region (Oehlmann
et al. 1994), and COMP mutations were identified in
patients with the Fairbank (Briggs et al. 1995a) and Rib-
bing (Ballo et al. 1997) types of MED. MED Fairbank
can also result from defects in the a2 chain of type IX
collagen (OMIM 600204 [http://www3.ncbi.nlm.nih
.gov:80/htbin-post/Omim/dispmim?600204]) (Briggs et
al. 1994; Muragaki et al. 1996) and from defects in at
least one additional gene (OMIM 600969 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/dispmim?
600969]) (Deere et al. 1995).
COMP is a 524-kD homopentameric glycoprotein
that is expressed prominently in the territorial matrix
surrounding chondrocytes (Hedbom et al. 1992). It is a
member of the thrombospondin gene family and is also
referred to as “thrombospondin 5.” COMP is a modular
protein containing an amino-terminal domain, four ep-
idermal growth factor–like repeats, eight calmodulin-
like (CaM-like) repeats, and a large carboxyl-terminal
globular domain (Oldberg et al. 1992). To date, all of
the reported COMP-gene mutations that result in
PSACH or MED phenotypes have been in the region of
the gene encoding the CaM-like domain (Briggs et al.
1995a; Hecht et al. 1995; Ballo et al. 1997; Loughlin et
al. [in press]). These have included point mutations that
result in single–amino acid substitutions for conserved
residues and in-frame deletions that delete codon(s) for
one or more residues.
We report the identification of mutations in an ad-
ditional 14 families with phenotypes within the PSACH-
MED disease spectrum. Twelve mutations were identi-
fied in the CaM-like domain; this finding confirms the
importance of this region in the structure and/or function
of COMP. We have also identified two mutations in the
carboxyl-terminal domain of COMP, thereby extending
the range of COMP-gene mutations that can produce
PSACH or MED phenotypes. These data provide evi-
dence that the carboxyl terminal domain of COMP has




The clinical and radiographic features of each patient
or family were reviewed by at least two clinical genet-
icists and/or radiologists. COMP mutations were iden-
tified in eight affected individuals who were sporadic
products of nonconsanguinous unions (International
Skeletal Dysplasia Registry reference numbers R91-064,
R92-207, R95-108, R95-109, and R95-110, and Uni-
versity of Gent patients BW, CM, andWL). The proband
in family R95-107 was the offspring of an affected father
and an unaffected mother. All affected individuals in
these families exhibited the typical clinical features of
PSACH: short-limb dwarfism, small hands with short
fingers, loose joints, a waddling gait, and varum and/or
valgum deformity of the lower limbs. Childhood radi-
ographs of all the patients were reviewed; they dem-
onstrated small, irregular epiphyses in the hands and
knees and irregular metaphyses. The hips exhibited mi-
croepiphyses and acetabular irregularities. Anterior
beaking of the vertebral bodies was apparent on lateral
projection. These features are diagnostic for typical
PSACH.
The pedigrees of the other five families in which
COMP mutations were identified are shown in figure 1.
The clinical features of these families are described
below.
Family R94-344 (MED Fairbank).—The proband, III-
1 (fig. 1), was first seen at 15 years of age. She was short
in stature (height 144 cm), and she complained of pain
in the knees. Her hands were normal. Radiographs
showed normal hands and hips, but the tibial epiphyses
were irregular, with a squared aspect. Her affected sister,
III-3, was also short in stature and had involvement of
the knees and hips. The femoral head was small and
irregular, but the severity of the deformities was some-
what less striking than the deformities in other cases of
MED Fairbank. The affected father (II-4) of the proband
had knee involvement, but the hips were unaffected. The
affected grandmother (I-2) had severe hip dysplasia that
required surgical replacement of the femoral head.
Family R83-130 (mild PSACH).—Affected individuals
were identified initially on the basis of their waddling
gaits. In childhood, they developed chronic hip pain that
was exacerbated by moderate exercise. Heights of the
affected individuals ranged from 145 cm (III-6, fig. 1)
to 180 cm (IV-2). Radiographs showed significant epi-
physeal and metaphyseal changes in the joints. The hips
showed microepiphyses and irregular acetabulae. The
spines showed platyspondyly and anterior beaking of
the vertebrae.
Family R92-002 (unclassified MED).—The earliest
symptoms included a waddling gait and lumbar lordosis.
The height of the only affected adult in the family (II-
2, fig. 1) was 147 cm. Radiographs showed small, ir-
regular epiphyses, particularly at the proximal femur,
and mild metaphyseal abnormalities. The hands were
atypical of PSACH or MED in that they were short, in
all segments, with irregular metaphyses and large epiph-
yses. In childhood, neither anterior beaking of the ver-
tebrae nor platyspondyly was apparent. The phenotype
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Figure 1 Pedigrees of five families in which COMP mutations were identified. The International Skeletal Dysplasia Registry reference
number is shown above each pedigree. Blackened symbols indicate affected individuals. Generations are indicated by roman numerals to the
left of each pedigree. Individuals within a generation are indicated by arabic numerals.
of the family is most consistent with a diagnosis ofMED,
but it has some features of PSACH. However, in some
respects, it resembles neither PSACH nor MED.
Family R93-237 (typical PSACH).—The male proband
was the first offspring of unaffected first-cousin parents
of Pakistani origin. Results of a prenatal fetal ultrasound
were normal, and the boy was normal at birth, with a
birth length at the 50th percentile. By 27 mo of age, his
height had fallen below the 5th percentile. At 6 years of
age, he was 91 cm tall (3d percentile), and he had mild
bowing of the lower extremities and some limitation of
movement at the elbows and knees. Radiographs
showed platyspondyly, with interpedicular narrowing in
the lumbar vertebrae, delayed ossification of the epiph-
yses of the long bones, widened metaphyses, and a flat-
tened acetabular roof. There was generalized brachy-
dactyly of the hands, with hypoplastic epiphyses and
cupped metaphyses.
Family R89-238 (typical PSACH).—The phenotype in
this family is characterized by marked short stature, a
waddling gait, pes varum, joint hyperlaxity, and pro-
gressive deformity at the knees, resulting in a “wind-
swept” appearance. Mild lordosis and scoliosis were
noted. At 6 years of age, the older sister (II-1, fig. 1)
underwent surgical correction of the knee deformity, but
by 12 years of age, medial deformity of the knees re-
curred. At 12 years of age, she was 119 cm tall (mean
height of a 6-year-old child) and had short, stubby
hands. Her affected younger sister (II-2) had a similar
phenotype and was 101 cm tall at 6.5 years of age (13
SD below the mean). Radiographs of both children
showed microepiphyses and irregular metaphyses of the
hips, and the vertebral bodies showed anterior beaking,
diagnostic for PSACH.
PCR Amplification and SSCP Analysis
PCR amplifications were performed in 100-ml reac-
tions, containing 1.5 mM MgCl2, 10 mM Tris-HCl, pH
8.3, 50 mM KCl, 200 mM each dNTP, 10 pmol each
primer, 50–100 ng genomic DNA, and 1 U Taq DNA
polymerase (Perkin-Elmer). Cycling conditions consisted
of an initial 3 min at 94C, followed by 35 cycles of 1
min at 94C, 1 min at 55C, and 1 min at 70C, with
a final incubation of 5 min at 70C. PCR products were
resolved by electrophoresis through nondenaturing 6%
polyacrylamide gels (37.5 acrylamide:1 bis) in 1# Tris-
Borate-EDTA buffer. COMP exons 10–19 were ana-
lyzed. Oligonucleotide sequences are given in table 1.
For SSCP analysis, 2 mCi a-[33P]dCTP was included in
the PCR reaction, and the products were resolved on
Hydrolink mutation detection electrophoresis gels (AT
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Table 1
Exons Amplified, Primer Names and Sequences, and Sizes of Amplified Products
Exon(s) Primer Names Primer Sequences
Product Size
(bp)
10 I9F1 5′-TGA GGA GTG TGA CCT TTG CC-3′ 279
I10R1 5′-AGC CGA ATC CCG CCT TCG GTG-3′
11 I10F1 5′-CTT GGG CTC TGG TCC CGT GG-3′ 181
I11R1 5′-GCT TAC CCA GCT GGA GTC TG-3′
12 I11F2 5′-ATT TCC TCT GTC TGA TTA TGG-3′ 168
I12R1 5′-CCA GAG ACA ATG AGC TCT CCAG-3′
13 I12F2 5′-GGG TAG CCT TTG ACA AAA CG-3′ 223
1492R 5′-GTT AGG CAC CAG GCG GCA G-3′
14 I13F1 5′-TGA CTT TAG CCC ACC GAG GG-3′ 281
I14R1 5′-CTC AGC ATA GGC CTC ACT GTG-3′
15 I14F1 5′-CAC AGT GAG GCC TAT GCT GA-3′ 164
I15R2 5′-GTG GCA GGA TAG CGC TGC TC-3′
16 I15F1 5′-GCG TTC GGA AAG GCC ACT GC-3′ 319
I16R1 5′-CTA AGT GGC TGT AAA GGG TTT-3′
17 I16F1 5′-GCC CAC CGA GGT CTC TGA CC-3′ 275
I17R1 5′-GGC ACT CCC ACC TGG GCC TG-3′
18/19 2116F 5′-GCG ATT CTA TGA GGG CCC TGA-3′ 319
2342R 5′-GCG GTG AGG GTG GCT GTC AT-3′
Biochem), according to the manufacturer’s protocol, ex-
cept that the gels were precooled and run for 2–3 h at
4C, at 50 W.
DNA Sequence Analysis
PCR products were cleaned by use of the QIAquick
kit (Qiagen) and were ligated into the pCRII TA cloning
vector (Invitrogen). DNA was isolated from the clones,
and sequences were determined by use of Sequenase and
reagents from a kit (US Biochemical). Direct sequence
analysis of PCR products was determined by means of
dye terminator chemistry followed by resolution on the
ABI PRISM 377 automated sequencer (Perkin-Elmer).
Results
The patient panel included 20 families with typical
PSACH, 2 families with mild PSACH, 6 families with
MED Fairbank, 3 families with MED Ribbing, and 13
families with unclassified forms of MED. By means of
heteroduplex, SSCP, and DNA sequence analysis, we
identified COMP-gene mutations in 14 individuals or
families who had phenotypes in the PSACH-MED clin-
ical spectrum. The phenotypes are detailed in the clinical
summary, the relevant pedigrees are shown in fig. 1, and
the mutations are summarized in table 2.
All individuals affected with typical PSACH, including
BW, WL, and members of families R89-238, R91-064,
R92-207, R95-108, and R95-110, were heterozygous
for a 3-bp deletion identified previously in patients with
this phenotype (Hecht et al. 1995). The deletion removed
one of five consecutive aspartic acid (GAC) codons cor-
responding to residues 469–473 of the protein, within
the seventh CaM-like repeat. The repeated nature of the
sequence (C GACGACGACGACGAC) does not allow
precise determination of the codon that is deleted in
these patients. We hypothesize that this repeat unit pre-
disposes to mutations of this type, which may occur via
slipped base pairing during DNA replication (Kunkel
1993; Ashley and Warren 1996). Ultrastructural studies
of cartilage from an individual in family R89-238
showed the typical accumulation of material with a la-
mellar appearance in the RER of chondrocytes that is
common in cases of PSACH (Cohn et al. 1996). Al-
though chondrocytes from R95-110 showed RER inclu-
sions with a smooth to grainy (rather than lamellar)
appearance (data not shown), cell preservationwas poor,
so few cells were examined.
A similar but shorter repeated sequence, C GAC GAC
GAC, is present in the portion of the COMP gene en-
coding the fourth CaM-like repeat. Deletion of one of
these aspartic acid codons, for residues 372–374 of the
protein, was reported previously in one patient with typ-
ical PSACH (Briggs et al. 1995a). The same mutation
was identified in another patient, also with typical
PSACH, from family R95-109. Chondrocytes from the
latter patient showed the characteristic lamellar RER
inclusions of PSACH (data not shown).
Patient CM and affected individuals in families R95-
107 and R93-237, all with typical PSACH, were het-
erozygous for point mutations predicted to result in a
single–amino acid substitution for glycine 440, within
the sixth CaM-like repeat. In families R95-107 and R93-
237, a GrA transition at the second position of the
codon predicted a G440E substitution (table 2). The
mutation could be identified on the basis of a slowly
Briggs et al.: COMP Mutations in PSACH and MED 315
Table 2
Mutations and Polymorphisms Identified in the COMP Gene in Patients with PSACH or MED
Family or Patient Nucleotide Change Exon Residue Change Domain Phenotype
R95-109 DGAC 1139–1147 10 DD 372–374 CaM-like #2 PSACH
R95-108a DGAC 1430–1444 13 DD 469–473 CaM-like #4 PSACH
CM GrA at 1343 13 G440R CaM-like #6 PSACH
R95-107b GrA at 1344 13 G440E CaM-like #6 PSACH
R94-344 ArG at 1383 13 N453S CaM-like #7 MED Fairbanks
R83-130 CrT at 1779 16 T585M COOH Mild PSACH
R92-002 CrG at 1779 16 T585R COOH MED
R83-130c GrA at 1780 16 Neutral polymorphism COOH . . .
a Also carried by families R89-238, R92-207, R95-110, and R91-64 and by patients BW and CM.
b Also carried by family R93-237.
c Also carried by family R92-002.
Figure 2 Sporadic COMPmutation (G440E) in family R93-237.
A, Sequences of the normal and mutant alleles are summarized. B,
PAGE of a PCR-amplified genomic DNA fragment containing the mu-
tation in the proband and in the parents. Lane 1 (m) shows size mark-
ers, with sizes (in bp) indicated on the left.
migrating heteroduplex in amplified genomic DNA (fig.
2). Despite the fact that the proband in family R93-237
was the offspring of a consanguinous union, the mu-
tation was not detected in amplified DNA from the un-
affected parents; this indicates that the PSACH pheno-
type was the result of a new mutation. In the family of
CM, an individual patient, a GrA transition at the first
position of the codon predicted a G440R substitution
(data not shown). Sequence analysis of an amplified ge-
nomic DNA fragment from both parents of CM showed
absence of the mutation; this demonstrates that the
PSACH phenotype was produced by a new dominant
mutation.
In families R83-130 and R92-002, who have domi-
nantly inherited forms of mild PSACH and MED, re-
spectively, we previously reported linkage of the disease
phenotypes to markers specific for the COMP locus on
chromosome 19, and we excluded linkage to markers
for COL9A1 and COL9A2 (Briggs et al. 1995b). In both
families, we identified point mutations that are predicted
to result in the substitution of threonine 585 in the car-
boxyl-terminal (COOH) domain of the protein. Ac-
cording to the previously published sequence (Newton
et al. 1994) and our own data, the codon for threonine
585 is ACG. In family R83-130 (individual IV-2), we
identified four clones with the sequence ATG and one
clone with the sequence ACA; the CrT transition pre-
dicted a T585M substitution, whereas the GrA tran-
sition was a silent polymorphism (fig. 3). In family R92-
002 (individual II-2), we identified three clones with the
sequence AGG and three clones with the sequence ACG;
the CrG transversion predicted a T585R substitution
(fig. 3). For all members of the two families, analysis of
PCR-amplified DNA from exon 16, by means of direct
sequence determination, confirmed the sequences of the
polymorphic alleles and demonstrated that the mutation
in each family cosegregated with the phenotype, without
exception (fig. 3).
In MED-Fairbank family R94-344, the disorder co-
segregated with markers from the COMP region of chro-
mosome 19, and linkage to COL9A1 and COL9A2 was
excluded (Briggs et al. 1995b). We identified an ArG
transition within the COMP gene that implied the sub-
stitution of a conserved asparagine residue by serine
(N453S), in the seventh CaM-like repeat (fig. 4). The
mutation created a BfaI restriction endonuclease cleav-
age site, and analysis of amplified DNA from family
members showed that the mutation cosegregated with
the phenotype (fig. 4).
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Figure 3 COMPmutations inMED family R92-002 and in mild-PSACH family R83-130.A, Summary of sequences. The normal (reported)
and polymorphic sequences are shown on the left, and the sequences of the abnormal alleles in each family are shown on the right.B,Cosegregation
of the mutation with the phenotype. Results of direct sequence analysis of a PCR-amplified DNA fragment, at codon 585, altered by the
mutation and/or polymorphism. The mutation or polymorphic sequence is underlined.
Discussion
Among the 22 families with typical PSACH—20 re-
ported here and 2 described in a previous report (Briggs
et al. 1995a)—7 (31.8%) had the same mutation, an in-
frame 3-bp deletion eliminating one of five consecutive
aspartate codons for residues 469–473 of the protein.
Deletion of one of three consecutive aspartate codons
(for residues 372–374) from the fourth CaM-like repeat
has now been identified in two patients, one described
in a previous study (Briggs et al. 1995a) and the other
described here. Thus, overall deletion mutations within
the CaM-like–repeat domain were seen in 9 (40.9%) of
the 22 patients with typical PSACH.
The data presented here also demonstrate that point
mutations in the CaM-like domain can produce typical
PSACH. In three unrelated individuals, we identified two
different point mutations in the codon for glycine 440
that result in its substitution by either arginine or glu-
tamic acid. The severity of the phenotype produced by
these mutations suggests that this residue plays a major
role in determining the structure and/or function of the
CaM-like domain of COMP. Although the three-dimen-
sional structure of the CaM-like domain of COMP is
unknown, the sequence of paramecium CaM shows that
glycine residues occur primarily at two positions (Kink
et al. 1990): (1) they are adjacent to aspartic acid or
asparagine residues within the calcium-binding pockets,
or (2) they are positioned to allow CaM to form hy-
drogen-bonded turns that separate neighboring helical
regions, and, as a result, they contribute to the secondary
structure of the protein. We speculate that glycine 440
is positioned to form a hydrogen-bonded turn that, if
disrupted, has a major effect on the overall structure of
this region of the protein, in that it affects the relative
positioning of calcium-binding pockets.
The N453S substitution identified in MED Fairbank
family R94-344 correlates well with the mutations pre-
viously reported to produce MED phenotypes. These
mutations result primarily in substitution of conserved
aspartic acid and asparagine residues within the CaM-
like domain, residues that are expected to line the cal-
cium-binding pockets and to bind calcium by charge-
charge interactions. The observation that suchmutations
usually produce MED provides support for our hypoth-
esis (Briggs et al. 1995a; Cohn et al. 1996) that these
mutations decrease the ability of individual calcium-
binding pockets to bind calcium, without producingma-
jor effects on the structure of this region of the molecule.
In two families, one with mild PSACH (R83-130) and
a second with a form of MED (R92-002), different sub-
stitutions for residue 585, in the carboxyl-terminal glob-
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Figure 4 COMP mutation in family R94-344. A, Summary of
sequence analysis predicting an N453S substitution. B, Cosegregation
of the mutation with the phenotype. PAGE of a BfaI-cleaved ampli-
fied–genomic DNA fragment containing the mutation. The pedigree
is shown above, with the numeric designations of generations and
individuals as described in the legend to figure 1. A line diagram of
the amplified fragment, with the locations of cleavage sites for BfaI
and the sizes of the resulting fragments, is shown below. The location
of the BfaI site created by the mutation is indicated by an asterisk (*).
ular domain of COMP, were identified. The mild-
PSACH family has typical radiographic features of the
spine, with anterior beaking of the vertebral bodies dur-
ing childhood and both metaphyseal and epiphyseal ab-
normalities. However, affected individuals in this family
exhibit either normal height or only mild short stature.
In contrast, the phenotype in the family with
MED—with primarily epiphyseal irregularities and a
normal spine—does not exhibit the radiographic fea-
tures of PSACH, but the only affected adult in the family
is of short stature. The clinical presentation of these fam-
ilies and the identification of COMP-gene mutations
demonstrate phenotypic overlap betweenMED andmild
forms of PSACH.
The mutations in the carboxyl-terminal domain in-
dicate that this region has an essential role in the struc-
ture and/or function of COMP. Although the precise role
is unknown, comparisons with the other members of the
thrombospondin family of proteins provide some sug-
gestions. Recent studies have shown that the carboxyl-
terminal domain of thrombospondin 1 contains a
non–RGD-dependent cell-binding domain based on the
sequence RFYVVMWK (Gao and Frazier 1994; Tsao
and Mousa 1995). This interaction, between thrombo-
spondin 1 and many cell types, appears to be mediated
by CD47 (Gao et al. 1996), an integrin-associated pro-
tein (IAP) that can bind to integrin avb3. Tuckwell et
al. (1994) determined the integrin profile of a human
chondrosarcoma cell line, HCS-2/8 (Takigawa et al.
1989), identifying avb3 as one of the expressed integrins.
The sequence SFYVVMWK is present in the carboxyl-
terminal domain of COMP (residues 608–615), sug-
gesting a similar role for this sequence in IAP
avb3–mediated chondrocyte interactions. Interestingly,
in vitro binding studies have shown that primary bovine
chondrocytes can attach to purified bovine COMP
(DiCesare et al. 1994), but the mechanism of this inter-
action is unknown. Threonine 585 is 23 amino residues
terminal to this putative cell attachment site and may
be involved in determining the secondary structure of
the domain. Future studies will examine the possibility
that the threonine 585 mutations affect the ability of
COMP to interact with chondrocytes.
Mutations were not identified in 8 PSACH patients
or in 20MED patients. For PSACH, linkage studies have
shown absence of locus heterogeneity (Hecht et al.
1993), so the mutations in the negative PSACH patients
are likely to result either from the known inefficiencies
of mutation detection by SSCP or from the possibility
that the mutations are in COMP exons not examined
in this study. For MED, the mutations may also be lo-
cated in genes other than COMP, including the type IX
collagen genes (Briggs et al. 1994;Muragaki et al. 1996).
The data presented here show that a variety of COMP
structural mutations can produce a continuum of dis-
ease, ranging from a typical PSACH to a mild MED-
Ribbing phenotype. Mutations predicted to disrupt the
secondary structure of the CaM-like domain of COMP
and to impede its secretion produce moderate to severe
forms of PSACH. Mutations predicted to have milder
effects on the secondary structure of the protein produce
phenotypes at the MED end of the clinical spectrum.
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